Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101,606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
Wei C, Wan L, Yan Q, Wang X, Zhang J, Yang X, Zhang Y, Fan C, Li D, Deng Y, Sun J, Gong J, Yang X, Wang Y, Wang X, Li J, Yang H, Li H, Zhang Z, Wang R, Du P, Zong Y, Yin F, Zhang W, Wang N, Peng Y, Lin H, Feng J, Qin C, Chen W, Gao Q, Zhang R, Cao Y, Zhong H. Wei C, et al. Among authors: zhang r, zhang w, zhang j, zhang z, zhang y. Nat Metab. 2020 Dec;2(12):1391-1400. doi: 10.1038/s42255-020-00324-0. Epub 2020 Nov 26. Nat Metab. 2020. PMID: 33244168
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, Zhang Z, Fan P, Dong Y, Yang Y, Chen Z, Guo Y, Zhang J, Li Y, Song X, Chen Y, Xia L, Fu L, Hou L, Xu J, Yu C, Li J, Zhou Q, Chen W. Chi X, et al. Among authors: zhang g, zhang j, zhang z, zhang y. Science. 2020 Aug 7;369(6504):650-655. doi: 10.1126/science.abc6952. Epub 2020 Jun 22. Science. 2020. PMID: 32571838 Free PMC article.
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination.
Chi X, Guo Y, Zhang G, Sun H, Zhang J, Li M, Chen Z, Han J, Zhang Y, Zhang X, Fan P, Zhang Z, Wang B, Zai X, Han X, Hao M, Fang T, Xu J, Wu S, Chen Y, Fang Y, Dong Y, Sun B, Zhang J, Li J, Zhao G, Yu C, Zhou Q, Chen W. Chi X, et al. Among authors: zhang g, zhang j, zhang z, zhang x, zhang y. Signal Transduct Target Ther. 2022 Apr 27;7(1):139. doi: 10.1038/s41392-022-00987-z. Signal Transduct Target Ther. 2022. PMID: 35478188 Free PMC article.
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.
Wang B, Xu J, Wu S, Zhang Z, Zhao Z, Zhang J, Fu L, Zai X, Wang Y, Zhang G, Chen Z, Chen Y, Sun H, Song X, Zhang J, Zhu L, Hou L, Chen W. Wang B, et al. Among authors: zhang g, zhang z, zhang j. Signal Transduct Target Ther. 2022 Jul 29;7(1):257. doi: 10.1038/s41392-022-01065-0. Signal Transduct Target Ther. 2022. PMID: 35906201 Free PMC article.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Zhu FC, et al. Among authors: zhang z, zhang j. Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20. Lancet. 2020. PMID: 32702299 Free PMC article. Clinical Trial.
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
Wu S, Huang J, Zhang Z, Wu J, Zhang J, Hu H, Zhu T, Zhang J, Luo L, Fan P, Wang B, Chen C, Chen Y, Song X, Wang Y, Si W, Sun T, Wang X, Hou L, Chen W. Wu S, et al. Among authors: zhang z, zhang j. Lancet Infect Dis. 2021 Dec;21(12):1654-1664. doi: 10.1016/S1473-3099(21)00396-0. Epub 2021 Jul 26. Lancet Infect Dis. 2021. PMID: 34324836 Free PMC article. Clinical Trial.
Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity.
Wu S, Zhang Z, Yu R, Zhang J, Liu Y, Song X, Yi S, Liu J, Chen J, Yin Y, Xu J, Hou L, Chen W. Wu S, et al. Among authors: zhang z, zhang j. Clin Vaccine Immunol. 2014 Feb;21(2):156-64. doi: 10.1128/CVI.00560-13. Epub 2013 Dec 4. Clin Vaccine Immunol. 2014. PMID: 24307239 Free PMC article.
101,606 results
You have reached the last available page of results. Please see the User Guide for more information.